Eikon Therapeutics, Inc.
EIKN
$10.73
$0.020.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.71% | 52.45% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -8.98% | 34.90% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 0.00% | 0.00% | -- | ||
| Total Current Assets | 3.30% | 51.76% | -- | ||
|
|
|||||
| Total Current Assets | 3.30% | 51.76% | -- | ||
| Net Property, Plant & Equipment | -2.15% | -2.02% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.24% | -30.03% | -- | ||
| Total Assets | -8.37% | 43.06% | -- | ||
|
|
|||||
| Total Accounts Payable | 9.31% | 781.79% | -- | ||
| Total Accrued Expenses | 34.47% | -33.84% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -3.03% | -2.87% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -25.55% | -- | ||
| Total Other Current Liabilities | -- | -25.55% | -- | ||
| Total Current Liabilities | 22.71% | -18.08% | -- | ||
|
|
|||||
| Total Current Liabilities | 22.71% | -18.08% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -0.95% | -0.89% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 50.00% | 0.00% | -- | ||
| Total Liabilities | 4.30% | -3.89% | -- | ||
|
|
|||||
| Common Stock & APIC | 0.27% | 3,647.17% | -- | ||
| Retained Earnings | -8.81% | -9.01% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -15.29% | 162.65% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -15.29% | 162.65% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -15.29% | 94.97% | -- | ||
|
|
|||||